Mayne Pharma Group Ltd (MYX.AX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
(Values in thousands)
| 06-2010 | 06-2009 | 06-2008 | 06-2007 | |
| Cash Flows From Operating Activities | ||||
| Operating Cash Flow | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Investing Activities | ||||
| PPE Investments | -399 | -4 | -10 | -62 |
| Net Acquisitions | -18,384 | N/A | N/A | N/A |
| Investing Cash Flow | $-18,783 | $-4 | $-10 | $-62 |
| Cash Flows From Financing Activities | ||||
| Debt Issued | 10,723 | N/A | N/A | N/A |
| Debt Repayment | -2,739 | N/A | N/A | N/A |
| Common Stock Issued | 14,161 | N/A | N/A | 16,915 |
| Common Stock Repurchased | -750 | N/A | -736 | -339 |
| Other Financing Activity | -1,095 | 0 | 0 | 0 |
| Financing Cash Flow | $20,299 | $0 | $-736 | $16,575 |
| Beginning Cash Position | 7,936 | 11,531 | 15,303 | 29 |
| End Cash Position | 19,709 | 7,936 | 11,531 | 15,303 |
| Net Cash Flow | $11,772 | $-3,594 | $-3,773 | $15,275 |
| Free Cash Flow | ||||
| Capital Expenditure | -399 | -4 | -10 | -62 |
| Free Cash Flow | -399 | -4 | -10 | -62 |